Genetic knockdown of the SM22α in VSMCS of both models resulted in accelerated AAA formation, elevated ROS production, and NFκB activation in AAA tissues, while overexpression resulted in opposite effects. The gene discussed is NFKB1; the disease is triple-A syndrome.